(Q33541428)

English

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Crohn's disease

0 references

Jürgen Schölmerich

5

object named as

Jürgen Schölmerich

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

object named as

Julian Panés

6

0 references

William Jeffery Sandborn

7

object named as

William J Sandborn

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Jean-Frédéric Colombel

2

object named as

Jean-Frédéric Colombel

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Stefan Schreiber

1

object named as

Stefan Schreiber

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Susanna Nikolaus

4

object named as

Susanna Nikolaus

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ralph Bloomfield

3

object named as

Ralph Bloomfield

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PRECiSE 2 Study Investigators

8

object named as

PRECiSE 2 Study Investigators

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

16 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1574-1582

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Diagnostics of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Biologics in inflammatory bowel disease: how much progress have we made?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Systematic review: tolerable amount of gluten for people with coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Biological therapies in inflammatory bowel disease: top-down or bottom-up?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Selective COX-2 Inhibitors: A Promise Unfulfilled?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.78

21 January 2018

Identifiers

10.1038/AJG.2010.78

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33541428&oldid=2195469748"